Related Experiment Video
Updated: May 21, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Survival after myocardial infarction according to left ventricular function and heart failure symptoms
Jarle Jortveit1, Peder L Myhre2,3, Kristian Berge3,4
1Department of Cardiology, Sorlandet Hospital, Arendal, Norway.
Insights
Patients with reduced left ventricular ejection fraction (LVEF) after acute myocardial infarction (AMI) face higher mortality. Heart failure symptoms at discharge significantly increase mortality risk, especially in those with preserved LVEF.
Area of Science:
- Cardiology
- Clinical Medicine
- Public Health
Background:
- Left ventricular (LV) dysfunction is a common complication post-acute myocardial infarction (AMI), even without overt heart failure (HF) symptoms.
- Previous trials suggest low event rates in post-AMI LV dysfunction, necessitating real-world outcome assessment.
Purpose of the Study:
- To evaluate the real-world prevalence and outcomes of patients post-AMI.
- To stratify outcomes based on left ventricular ejection fraction (LVEF) and the presence of HF symptoms.
Main Methods:
- A cohort study utilizing data from the Norwegian Myocardial Infarction Registry (2013-2022).
- Analysis included short- and long-term all-cause mortality using Kaplan-Meier curves, Life Table, and Cox regression models.
Main Results:
- Among 70,809 AMI patients, 13.3% had reduced LVEF (≤40%), with 63.2% symptomatic for HF.
- 1-year mortality rates varied significantly by LVEF and HF symptoms, reaching 20.2% in symptomatic patients with reduced LVEF.
- Symptomatic patients had a higher mortality risk (adjusted HR 1.15-1.85) compared to asymptomatic individuals across LVEF categories.
Conclusions:
- Reduced LVEF post-AMI is linked to substantial 1-year mortality, exceeding rates seen in recent trials.
- Heart failure symptoms during hospitalization worsen outcomes, particularly for patients with preserved LVEF, but add less risk to those with already reduced LVEF.
Aims:
Left ventricular (LV) dysfunction following acute myocardial infarction (AMI) is common even in the absence of signs and symptoms of heart failure (HF). Recent trials of patients with LV dysfunction post-AMI have demonstrated low event rates during follow-up. We aimed to assess the real-world prevalence and outcomes post-AMI, stratified by LV ejection fraction (LVEF) and the presence or absence of HF symptoms.
Methods And Results:
Cohort study of patients with AMI registered in the Norwegian Myocardial Infarction Registry 2013-2022. Outcomes were short- and long-term all-cause mortality. Mortality was assessed by Kaplan-Meier survival curves, Life Table and multivariable Cox regression models.
Results:
Among 70 809 AMI patients (mean age 68.1 ± 12.9 years, 31% female), preserved (≥50%), mildly reduced (41%-49%) and reduced (≤40%) LVEF were present in 63.5%, 23.2% and 13.3%, respectively. Symptomatic HF was present in 3.3%, 28.1% and 63.2% of patients with preserved, mildly reduced and reduced LVEF. For each LVEF category, 1-year cumulative mortality rate from discharge was 3.9%, 7.8% and 17.8% for asymptomatic, and 16.2%, 13.7% and 20.2% for symptomatic patients, respectively. Symptomatic patients discharged alive had higher risk of mortality than asymptomatic: adjusted hazard ratio 1.85 (1.70-2.02) for preserved LVEF, 1.33 (1.25-1.41) for mildly reduced LVEF and 1.15 (1.06-1.24) for reduced LVEF.
Conclusions:
Reduced LVEF in the acute phase of AMI was associated with up to 20% 1-year mortality after discharge, substantially higher than in recent post-MI trials. Symptoms of HF during the index hospitalization were associated with worse outcomes in patients with preserved LVEF but contributed little additive risk for patients with reduced LVEF.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: β-Blockers
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

